DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) hit a new 52-week low during mid-day trading on Friday. The stock traded as low as $9.35 and last traded at $9.4250, with a volume of 1640398 shares changing hands. The stock had previously closed at $9.53.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on XRAY shares. Weiss Ratings reiterated a "sell (e+)" rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. BMO Capital Markets lowered their price target on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating on the stock in a report on Thursday, September 17th. Barclays lifted their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an "underweight" rating in a research report on Monday, August 24th. Barrington Research set a $15.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, August 10th. Finally, Piper Sandler increased their target price on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a "neutral" rating in a research report on Wednesday, July 29th. Three equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $13.31.
Read Our Latest Report on DENTSPLY SIRONA
DENTSPLY SIRONA Trading Down 1.5%
The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48. The stock has a 50-day simple moving average of $11.62 and a 200 day simple moving average of $11.37. The company has a market cap of $1.87 billion, a price-to-earnings ratio of -3.42, a PEG ratio of 1.27 and a beta of 0.84.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.17. The firm had revenue of $898.00 million for the quarter, compared to analyst estimates of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The business's quarterly revenue was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current fiscal year.
Institutional Trading of DENTSPLY SIRONA
Institutional investors have recently bought and sold shares of the business. Envestnet Portfolio Solutions Inc. raised its stake in DENTSPLY SIRONA by 42.6% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 60,828 shares of the medical instruments supplier's stock valued at $645,000 after purchasing an additional 18,181 shares during the last quarter. Tidal Investments LLC boosted its stake in DENTSPLY SIRONA by 13.1% during the 2nd quarter. Tidal Investments LLC now owns 371,967 shares of the medical instruments supplier's stock worth $3,947,000 after purchasing an additional 43,025 shares during the last quarter. Engineers Gate Manager LP grew its holdings in shares of DENTSPLY SIRONA by 451.5% during the second quarter. Engineers Gate Manager LP now owns 124,810 shares of the medical instruments supplier's stock worth $1,324,000 after buying an additional 102,179 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $791,000. Finally, Allworth Financial LP raised its position in shares of DENTSPLY SIRONA by 163.8% in the second quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier's stock valued at $51,000 after buying an additional 2,990 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.
DENTSPLY SIRONA Company Profile
(
Get Free Report)
DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.
Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.